4.6 Article

Radiochemical and Biological Evaluation of 3p-C-NETA-ePSMA-16, a Promising PSMA-Targeting Agent for Radiotheranostics

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker

Holis Abdul Holik et al.

Summary: Research on therapeutic radiopharmaceuticals has been increasing in importance, with radiometal-based drugs gaining significant attention. Researchers can use the characteristics of various commonly used chemical components provided in this paper as a guide.

MOLECULES (2022)

Article Medicine, Research & Experimental

3p-C-NETA: A versatile and effective chelator for development of Al18F-labeled and therapeutic radiopharmaceuticals

Stephen Ahenkorah et al.

Summary: In this study, a novel chelator 3p-C-NETA was evaluated for its potential therapeutic and diagnostic applications. [F-18]-labeled 3p-C-NETA-TATE showed good stability and pharmacokinetic properties similar to [F-18]AlF-NOTA-Octreotide, indicating its potential as a new theranostic chelator for clinical nuclear medicine applications.

THERANOSTICS (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with 67Cu

Lachlan E. McInnes et al.

Summary: 67Cu-CuSarbisPSMA demonstrates therapeutic potential in a PSMA-expressing model of prostate cancer, with the ability to inhibit tumor growth and improve survival rates.

JOURNAL OF NUCLEAR MEDICINE (2021)

Article Medicine, Research & Experimental

Evaluation of 177Lu and 47Sc Picaga-Linked, Prostate-Specific Membrane Antigen-Targeting Constructs for Their Radiotherapeutic Efficacy and Dosimetry

Brett A. Vaughn et al.

Summary: Lu-177-based targeted radiotherapeutics show promising results in treating PSMA-expressing tumors, leading to tumor regression and prolonged median survival compared to other treatment options.

MOLECULAR PHARMACEUTICS (2021)

Article Medicine, General & Internal

Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

Oliver Sartor et al.

Summary: The radioligand therapy with Lu-177-PSMA-617 prolonged both imaging-based progression-free survival and overall survival in patients with PSMA-positive metastatic castration-resistant prostate cancer when added to standard care. Adverse events were more common with Lu-177-PSMA-617 but did not significantly impact quality of life.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Radiolabeling of Human Serum Albumin With Terbium-161 Using Mild Conditions and Evaluation of in vivo Stability

Irwin Cassells et al.

Summary: Targeted radionuclide therapy, using terbium isotopes for imaging and treatment, is a promising approach for cancer therapy. The study evaluated potential bifunctional chelators for labeling heat-sensitive biomolecules with terbium. Results showed that certain chelators are suitable for terbium-based radiopharmaceuticals, allowing for high yield radiolabeling in mild conditions.

FRONTIERS IN MEDICINE (2021)

Article Medicine, Research & Experimental

Therapeutic Efficacy of 213Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer

Yana Dekempeneer et al.

MOLECULAR PHARMACEUTICS (2020)

Article Biochemistry & Molecular Biology

The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research

Nathalie Percie du Sert et al.

PLOS BIOLOGY (2020)

Article Chemistry, Medicinal

Automated GMP compliant production of [18F]AlF-NOTA-octreotide

Terence Tshibangu et al.

EJNMMI RADIOPHARMACY AND CHEMISTRY (2020)

Article Chemistry, Organic

A novel clickable MSAP agent for dual fluorescence/nuclear labeling of biovectors

Kuo-Ting Chen et al.

ORGANIC & BIOMOLECULAR CHEMISTRY (2020)

Article Biochemical Research Methods

Clinical translation of theranostic radiopharmaceuticals: Current regulatory status and recent examples

Petra Kolenc Peitl et al.

JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2019)

Article Chemistry, Analytical

Maintaining radiochemical purity of [177Lu]Lu-DOTA-PSMA-617 for PRRT by reducing radiolysis

Rory M. S. de Zanger et al.

JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2019)

Review Chemistry, Multidisciplinary

Radioactive Main Group and Rare Earth Metals for Imaging and Therapy

Thomas I. Kostelnik et al.

CHEMICAL REVIEWS (2019)

Article Medicine, General & Internal

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

J. Strosberg et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

Automated synthesis of [18F]DCFPyL via direct radiofluorination and validation in preclinical prostate cancer models

Vincent Bouvet et al.

EJNMMI RESEARCH (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer

Martina Benesova et al.

JOURNAL OF NUCLEAR MEDICINE (2015)

Article Chemistry, Analytical

Retention of [18F]fluoride on reversed phase HPLC columns

Dieter Ory et al.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

Synthesis and evaluation of a new bifunctional NETA chelate for molecular targeted radiotherapy using 90Y or 177Lu

Chi Soo Kang et al.

NUCLEAR MEDICINE AND BIOLOGY (2015)

Article Pharmacology & Pharmacy

Alternative Method to Determine Specific Activity of 177Lu by HPLC

Wouter A. P. Breeman et al.

CURRENT RADIOPHARMACEUTICALS (2015)

Review Chemistry, Multidisciplinary

Matching chelators to radiometals for radiopharmaceuticals

Eric W. Price et al.

CHEMICAL SOCIETY REVIEWS (2014)

Article Biochemical Research Methods

68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging

Matthias Eder et al.

BIOCONJUGATE CHEMISTRY (2012)

Review Biochemistry & Molecular Biology

Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer

C. Barinka et al.

CURRENT MEDICINAL CHEMISTRY (2012)

Article Biochemical Research Methods

Efficient Bifunctional Decadentate Ligand 3p-C-DEPA for Targeted α-Radioimmunotherapy Applications

Hyun A. Song et al.

BIOCONJUGATE CHEMISTRY (2011)

Article Chemistry, Medicinal

Synthesis and evaluation of a bifunctional chelate for development of Bi(III)-labeled radioimmunoconjugates

Mamta Dadwal et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)

Article Radiology, Nuclear Medicine & Medical Imaging

A Novel Method of 18F Radiolabeling for PET

William J. McBride et al.

JOURNAL OF NUCLEAR MEDICINE (2009)

Article Chemistry, Medicinal

Efficient synthesis and evaluation of bimodal ligand NETA

Hyun-Soon Chong et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)

Article Chemistry, Medicinal

Synthesis and evaluation of novel polyaminocarboxylate-based antitumor agents

Hyun-Soon Chon et al.

JOURNAL OF MEDICINAL CHEMISTRY (2008)

Article Radiology, Nuclear Medicine & Medical Imaging

In vitro and in vivo evaluation of novel ligands for radioimmunotherapy

Hyun-Soon Chong et al.

NUCLEAR MEDICINE AND BIOLOGY (2006)